session 3
Utilization & Exploitation of Human Spaceflight Systems
- type
oral
- Description
This session addresses the utilization and exploitation of space stations and human spacecraft and provides the opportunity to discuss achievements, plans and outlooks. Topics for discussion include proposed or available payload facilities, experiments, research, manufacturing, and other on-orbit activity and its related planning, accommodation, and implementation. Additional items appropriate for discussion include scientific and industrial utilization applications and engineering research and technology demonstrations, as well as uses of space stations (ie. International Space Station and Tjangong) and other manned vehicles as test beds for exploration.
- Date
2016-09-27
- Time
- Room
- IPC members
Co-Chair: Mr. Kevin D. Foley, The Boeing Company, United States;
Co-Chair: Dr. Annamaria Piras, Thales Alenia Space Italia, Italy;
Rapporteur: Mr. Shannon Ryan, Defence Science and Technology Organisation (DSTO), Australia;
Order | Time | Paper title | Mode | Presentation status | Speaker | Affiliation | Country |
---|---|---|---|---|---|---|---|
1 | 20' | confirmed | Dr. Camille Alleyne | NASA | United States | ||
2 | ESA's Future Utilisation Programme for the ISS and complementary platforms | 20' | confirmed | Dr. Marc Heppener | European Space Agency (ESA) | The Netherlands | |
3 | 20' | confirmed | Dr. George Karabadzhak | Central Research Institute for Machine Building (FGUP TSNIIMASH) | Russian Federation | ||
4 | Canadian Space Agency Utilisation of the International Space Station in 2015 | 20' | confirmed | Dr. Nicole Buckley | Canadian Space Agency | Canada | |
5 | 20' | confirmed | Mr. Keiichiro Sakagami | Japan Aerospace Exploration Agency (JAXA) | Japan | ||
6 | Orphan drug development for Duchenne muscular dystrophy by protein crystallization in space | 20' | confirmed | Dr. Yoshihiro Urade | Osaka Bioscience Institute | Japan | |
7 | Opportunities for Low-Earth Orbit Utilization, Current and Future | 20' | confirmed | Mr. Jeffrey Manber | Nanoracks LLC | United States | |
8 | 20' | confirmed | Mr. Matthew Duggan | The Boeing Company | United States | ||
9 | Conceptual Design of a Human Spaceflight Platform as ISS successor | 20' | confirmed | Mr. Marius Schwinning | University of Stuttgart | Germany | |
10 | Life in low-Earth orbit after the International Space Station | 20' | confirmed | Mr. Sam Scimemi | National Aeronautics and Space Administration (NASA) | United States |